PATENT CLAIM ANALYSIS

Application Number: 15943278
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "250000"]

Abstract:
This invention is in the area of improved compounds, compositions and methods of transiently protecting healthy cells, and in particular hematopoietic stem and progenitor cells (HSPC) as well as renal cells, from damage associated with DNA damaging chemotherapeutic agents. In one aspect, improved protection of healthy cells is disclosed using disclosed compounds that act as highly selective and short, transiently-acting cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors when administered to subjects undergoing DNA damaging chemotherapeutic regimens for the treatment of proliferative disorders.

Claim (Index 9):
The compound of  claim 1 , of Formula:

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.46032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15288878', '14212430', '14212911', '15342990', '15387083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8495283322331159
- 35 USC 102 Novelty (BERT): 0.578683436387891
- Combined Prediction Score: 0.8224438426485934
- Mean Citation Score: 606.5120479999998
- Max Citation Score: 679.1801
- Similarity Product: 352.15445694789884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test